Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Divi's Laboratories Ltd.
NSE: DIVISLAB
|
BSE: 532488
|
ISIN: INE361B01024
|
Industry: Pharmaceuticals
|
Expensive Performer
6561.0000
5.00
(
0.08
%)
NSE
Oct 14, 2025
15:31 PM
32.41% Gain from 52W Low
Volume:
321.3K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Divi's Laboratories Ltd.
04 Feb 2023
6561.00
0.08%
Divi's Labs (HOLD): Big miss on revenue and margins
Hold:
Divi's Laboratories Ltd.
by
BOB Capital Markets Ltd.
Target: 3200
Target
BOB Capital Markets Ltd.
Q3 disappoints as revenue/PAT of Rs 17bn/Rs 3bn missed consensus by 12%/38%
Divi's Laboratories .. has an
average target
of 6414.33 from 6 brokers.
More from Divi's Laboratories Ltd.
Recommended
Market closes lower, ICICI Prudential's Q2 revenue falls 52% YoY
Trendlyne Marketwatch |
14 Oct 2025, 04:05PM
IPO market cools: LG Electronics, Canara Robeco, plus seven listings, and a new issue
|
13 Oct 2025, 04:01PM
Custom synthesis business drives growth for Divi’s Laboratories
|
10 Mar 2022